MONTRAL TAB

About

Montral Tab, containing Montelukast, is a leukotriene receptor antagonist primarily used in the management of asthma and allergic rhinitis. It works by blocking the action of leukotrienes, which are inflammatory mediators released in the body. By inhibiting these substances, Montelukast helps to reduce inflammation, bronchoconstriction, and mucus secretion in the airways, thereby improving respiratory function and alleviating symptoms. It is effective in preventing asthma attacks and controlling chronic asthma symptoms, as well as providing relief from seasonal and perennial allergic rhinitis. This medication is not intended for the treatment of acute asthma attacks but rather for long-term control and prevention.

Uses

• Prevention and chronic treatment of asthma.
• Relief of symptoms of seasonal allergic rhinitis.
• Relief of symptoms of perennial allergic rhinitis.
• Prevention of exercise-induced bronchoconstriction.

Directions For Use

Take one tablet orally once daily, typically in the evening, with or without food, as directed by your physician.

Benefits

• Effectively prevents asthma attacks.
• Reduces inflammation in the airways.
• Provides significant relief from allergy symptoms.
• Improves overall lung function.
• Offers convenient once-daily dosing.
• Generally well-tolerated with a non-sedating profile.

Side Effects

• Headache
• Abdominal pain
• Nausea
• Diarrhea
• Dizziness
• Fatigue
• Rash
• Cough
• Flu-like symptoms
• Insomnia
• Behavioral changes (e.g., agitation, anxiety)
• Eosinophilia

Safety Measures

• Alcohol - Generally, alcohol consumption is not contraindicated with Montelukast, but excessive intake may exacerbate some side effects like dizziness or headache.
• Pregnancy - Consult your doctor before use. Montelukast should be used during pregnancy only if clearly needed and the potential benefits outweigh the risks.
• Breastfeeding - Consult your doctor. Small amounts of Montelukast may pass into breast milk; monitor the infant for any adverse effects.
• Liver - Use with caution in patients with severe liver impairment. Dose adjustment may be considered in such cases, and liver function should be monitored.
• Kidney - No specific dose adjustment is typically required for patients with renal impairment, as Montelukast is primarily metabolized by the liver.
• Lung - Montelukast is for chronic management and prevention; it is not for the relief of acute asthma attacks. Continue other prescribed asthma medications.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.